✦ LIBER ✦

Economic implications of non-adherence to treatment recommendations for hemodialysis patients with anemia

✍ Scribed by Laura T. Pizzi; Nikita M. Patel; Vittorio M. Maio; David S. Goldfarb; Beckie Michael; Joseph P. Fuhr; Neil I. Goldfarb

Publisher: Wiley (John Wiley & Sons)
Year: 2006
Tongue: English
Weight: 149 KB
Volume: 35
Category: Article
ISSN: 0090-2934
DOI: 10.1002/dat.20064

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recommendations for the Health Economics

Recommendations for the Health Economics Analysis to be Performed with a Drug to be Registered in Prevention or Treatment of Osteoporosis

✍ W. Dere; B. Avouac; M. Boers; M. Buxton; C. Christiansen; A. Dawson; C. Gennari; 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 40 KB

Treatment of tics in patients with Toure

Treatment of tics in patients with Tourette syndrome: Recommendations according to the European Society for the Study of Tourette Syndrome

✍ Kirsten R. Müller-Vahl; Veit Roessner; on behalf of the European Society for the 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

Reply to: Treatment of tics in patients

Reply to: Treatment of tics in patients with Tourette syndrome: Recommendations according to the European Society for the Study of Tourette Syndrome

✍ Joseph Jankovic; Roger Kurlan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

Treatment outcomes in patients with non-

Treatment outcomes in patients with non-infectious aortic valvulitis undergoing aortic valve replacement: implication for the treatment of aortic valve involvement in Behcet’s disease

✍ Joong Kyong Ahn; Hyungjin Kim; Jaejoon Lee; Pyo-Won Park; Chan Hong Jeon; Eun-Mi 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 245 KB

Evaluation of effective return-to-work t

Evaluation of effective return-to-work treatment programs for sick-listed patients with non-specific musculoskeletal complaints: a systematic review

✍ Eline M. Meijer; Judith K. Sluiter; Monique H. W. Frings-Dresen 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 287 KB

Phase 1-2 trial of PTK787/ZK222584 combi

Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma : Implication for antiangiogenic approach to hepatocellular carcinoma

✍ Thomas Yau; Pierre Chan; Roberta Pang; Kelvin Ng; S. T. Fan; Ronnie T. Poon 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

## Abstract ## BACKGROUND: This phase 1‐2 trial assessed the efficacy and tolerability of an oral angiogenesis inhibitor—PTK787/ZK222584 (PTK)—in combination with intravenous doxorubicin for the treatment of advanced hepatocellular carcinoma (HCC) patients. ## METHODS: In phase 1, advanced HCC p